Totrombopag

CAS No. 376592-42-6

Totrombopag( —— )

Catalog No. M34722 CAS No. 376592-42-6

Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 787 In Stock
10MG 1074 In Stock
25MG 1511 In Stock
50MG 1841 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG 4557 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Totrombopag
  • Note
    Research use only, not for human use.
  • Brief Description
    Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
  • Description
    Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    RSV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    376592-42-6
  • Formula Weight
    466.49
  • Molecular Formula
    C25H22N8O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(N=C(C)C1N=NC2=C(O)C(=CC=C2)C3=CC(=CC=C3)C=4NN=NN4)C5=CC(C)=C(C)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nirsevimab

    Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region, efficiently targeting RSV-B with a Kd value of 1.5 nM, and can be used to prevent RSV infection.

  • NSC 311068

    NSC 311068 is a small molecule that directly tragets and inhibits STAT3/5.

  • STA-21

    A small-molecule inhibitor of STAT3; inhibits Stat3 DNA binding activity, Stat3 dimerization, and Stat3-dependent luciferase activity (20-30 uM).